Floatz logo

Elafibranor

Prediabetes Syndrome

GenfitSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

46 Active assets in the Prediabetes Syndrome cohort.

Asset / SponsorPhaseRating
Metformin
Yu Chen
Phase 4A
Liraglutide
Woman's
Phase 4BBB
Semaglutide
Esbjerg Hospital - University Hospital of Southern Denmark
Phase 4BBB
Exenatide
RenJi Hospital
Phase 4BBB
Empagliflozin
The University of Texas Health Science Center at San Antonio
Phase 4BBB

View all 50 →

Same molecule, other indications

Elafibranor is also rated in:

metabolic dysfunction-associated steatohepatitisDormant
BB
Indicative ·
66 / 100
View asset →
Abdominal ObesityDormant
BB
Indicative ·
66 / 100
View asset →
primary biliary cholangitisDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →